The supplementary GM-CSF to neoadjuvant gemicitabine-cisplatin systemic chemotherapy plus PD-L1 blockade decrease local tumor recurrence of urothelial carcinoma after surgery via suppression of MDSCs in blood and tumor microevironment

The supplementary GM-CSF to neoadjuvant gemicitabine-cisplatin systemic chemotherapy plus PD-L1 blockade decrease local tumor recurrence of urothelial carcinoma after surgery via suppression of MDSCs in blood and tumor microevironment

Bibliographic Details
Main Authors: M. Miyake, S. Hori, N. Nishimura, T. Owari, Y. Itami, Y. Nakai, N. Tanaka, K. Fujimoto
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320326112

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320326112

Similar Items